In this third and final part of our translational cell and gene therapy webinar series we delve into cell therapy applications beyond immune oncology.
Firstly, we will look into Miltenyi Biotec’s complete workflow solution for the study of virus-specific T cells and their production as clinical-grade products for cell therapy applications in the field of infectious diseases.
We will also introduce our manual workflow solutions for pluripotent stem cell (PSC) culture and maintenance, followed by an introduction to our GMP-compliant PSC expansion using the CliniMACS Prodigy® platform and the iPS-Brew GMP Medium, which could provide a ready-to-use solution for human PSC banking.
- Understand the process to isolate virus-specific T cells and their production as clinical-grade products for infectious diseases
- Gain insights into the efficient cultivation and expansion of pluripotent stem cells
- See how to achieve GMP-compliant expansion of PSCs in an automated and ready-to-use fashion
